Franck Rouby

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

Marion Allouchery, Thomas Lombard, M. Martin et al. · Journal for ImmunoTherapy of Cancer · 2020 · 117 citations · Full text

Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort

Florence Daviet, Franck Rouby, Pascale Poullin et al. · British Journal of Clinical Pharmacology · 2018 · 60 citations · Full text

Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database

Julie Garon-Czmil, Nadine Petitpain, Franck Rouby et al. · Scientific Reports · 2019 · 59 citations · Full text

Acute Coronary Syndrome With Immune Checkpoint Inhibitors: A Proof-of-Concept Case and Pharmacovigilance Analysis of a Life-Threatening Adverse Event

Jennifer Cautela, Franck Rouby, Joe‐Elie Salem et al. · Canadian Journal of Cardiology · 2019 · 49 citations · Full text

Thrombosis, Translational Medicine, Cardiovascular Disease +12

Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions

Louis Létinier, Julien Jouganous, M. Benkebil et al. · Clinical Pharmacology & Therapeutics · 2021 · 43 citations · Full text